IRVINE, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Endologix, Inc. , developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at three upcoming investor conferences. The first presentation will be at the Canaccord Adams 3rd Annual Cardiovascular Conference at the Nikko Hotel in San Francisco, CA.
The second presentation will be at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City.
An audio Web cast of the Company’s presentations will be available by visiting the investor relations section of Endologix’s Web site at www.endologix.com. A replay of the presentations will be available for 30 days.
CONTACT: John McDermott, CEO, Endologix, Inc., +1-949-595-7200; or for
Investors, Nick Laudico, +1-646-536-7030 or Zack Kubow, +1-646-536-7020,
both of The Ruth Group
Web site: http://www.endologix.com/
